9,105 Shares in Option Care Health, Inc. (NASDAQ:OPCH) Bought by Florida Financial Advisors LLC

Florida Financial Advisors LLC acquired a new position in Option Care Health, Inc. (NASDAQ:OPCH) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 9,105 shares of the company’s stock, valued at approximately $211,000.

Several other institutional investors have also added to or reduced their stakes in OPCH. UMB Bank n.a. raised its position in shares of Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock worth $27,000 after acquiring an additional 346 shares in the last quarter. Signaturefd LLC increased its stake in shares of Option Care Health by 487.9% in the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock valued at $28,000 after acquiring an additional 1,005 shares in the last quarter. Quarry LP lifted its position in shares of Option Care Health by 327.7% during the 3rd quarter. Quarry LP now owns 3,430 shares of the company’s stock valued at $107,000 after acquiring an additional 2,628 shares during the period. Blue Trust Inc. boosted its stake in Option Care Health by 16.9% during the fourth quarter. Blue Trust Inc. now owns 4,703 shares of the company’s stock worth $109,000 after acquiring an additional 681 shares in the last quarter. Finally, Venturi Wealth Management LLC increased its stake in Option Care Health by 2,621.3% in the fourth quarter. Venturi Wealth Management LLC now owns 4,735 shares of the company’s stock valued at $110,000 after purchasing an additional 4,561 shares in the last quarter. 98.05% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

OPCH has been the subject of several research reports. Jefferies Financial Group upgraded Option Care Health from a “hold” rating to a “buy” rating and raised their target price for the company from $26.00 to $35.00 in a research note on Thursday, January 23rd. Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and raised their price target for the company from $26.00 to $33.00 in a research report on Monday, January 13th. JPMorgan Chase & Co. raised their target price on Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a report on Thursday, March 6th. JMP Securities restated a “market outperform” rating and issued a $30.00 price objective (down previously from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Finally, Barrington Research boosted their target price on shares of Option Care Health from $33.00 to $38.00 and gave the company an “outperform” rating in a research note on Thursday, February 27th. Two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $33.00.

Option Care Health Trading Up 1.4 %

Shares of Option Care Health stock opened at $35.18 on Wednesday. The company’s 50-day moving average price is $32.11 and its 200-day moving average price is $28.33. The company has a market cap of $5.78 billion, a price-to-earnings ratio of 29.56, a PEG ratio of 2.30 and a beta of 1.33. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $35.44. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77.

Insider Activity

In related news, insider Michael Bavaro sold 30,996 shares of the firm’s stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares of the company’s stock, valued at $1,495,835.24. This trade represents a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 0.64% of the company’s stock.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.